' x='0' y='0' width='795' height='447'%3E%3C/rect%3E%3Ctext id='Loading-Preview' font-family='AvenirNext-Bold, Avenir Next' font-size='42' font-weight='bold' fill='%23FFFFFF'%3E%3Ctspan x='228.715' y='211'%3ELoading Preview%3C/tspan%3E%3C/text%3E%3C/g%3E%3C/g%3E%3C/svg%3E)
Description | Kriya is a biopharmaceutical company developing gene therapy to address common diseases that impact millions of people worldwide. Learn more. |
h1 tags | Gene Therapy. Redefined. |
h2 tags | Therapeutic Program Areas In the News Kriya Announces Presentations at ASGCT 2026 Highlighting Advances Across Gene Therapy Platform Kriya Appoints Sachiyo Minegishi as Chief Financial Officer Kriya appoints Greg Di Russo, MD as Chief Medical Officer Our Investors |
Site Speed | 0.63660907745361 |
Alexa Rank: |
0 |
Site's Traffic |
|
| Host | Type | Class | TTL | Target |
| kriyatherapeutics.com | HINFO | IN | 3600 |